<SEC-DOCUMENT>0000950123-09-040121.txt : 20120626
<SEC-HEADER>0000950123-09-040121.hdr.sgml : 20120626
<ACCEPTANCE-DATETIME>20090901152230
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000950123-09-040121
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20090901

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CALAMOS GLOBAL TOTAL RETURN FUND
		CENTRAL INDEX KEY:			0001285650
		IRS NUMBER:				203377281
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		2020 CALAMOS COURT
		STREET 2:		C/O CALAMOS ADVISORS LLC
		CITY:			NAPERVILLE
		STATE:			IL
		ZIP:			60563
		BUSINESS PHONE:		6302451046

	MAIL ADDRESS:	
		STREET 1:		2020 CALAMOS COURT
		STREET 2:		C/O CALAMOS ADVISORS LLC
		CITY:			NAPERVILLE
		STATE:			IL
		ZIP:			60563
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
<TITLE>corresp</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="60%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="38%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD rowspan="2" valign="top"><DIV style="margin-left:0px; text-indent:-0px"><IMG src="c53132c1c5313205.gif" alt="(K&#038;L GATES LOGO)">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">K&#038;L Gates <FONT style="font-variant: SMALL-CAPS">llp</font></TD>
</TR>
<TR valign="bottom">

    <TD>&nbsp;</TD>
    <TD align="left" valign="top">1601 K Street NW</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Washington, DC 20006-1600</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">T 202.778.9000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;www.klgates.com</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">September&nbsp;1, 2009
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 50%">Eric S. Purple<BR>
D 202.778.9220<BR>
F 202.778-9100<BR>
eric.purple@klgates.com

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>By E-mail and EDGAR</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Mr.&nbsp;Larry Greene<BR>
Division of Investment Management<BR>
Securities and Exchange Commission<BR>
100 F Street, N.E., Room&nbsp;4700<BR>
Washington, D.C. 20549

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Attn: Mr.&nbsp;Larry Greene
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">Re:</TD>
    <TD width="1%">&nbsp;</TD>
    <TD> Calamos Global Total Return Fund (File Nos. 333-146944 and 811-21547) Registration<br> Statement
on Form N-2 Relating to Universal Shelf Offering</TD>
</TR>

</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Dear Mr.&nbsp;Greene:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On August&nbsp;21, 2009, Calamos Global Total Return Fund (the &#147;<B><I>Fund</I></B>&#148;) filed Post-Effective
Amendment No.&nbsp;2 to its Registration Statement on Form N-2 (the &#147;<B><I>Amendment</I></B>&#148;) for the purpose of: (1)
providing updated financial information and (2)&nbsp;making conforming language changes in response to
the Commission staff&#146;s comments on substantially identical disclosure contained in the Registration
Statements for certain related funds, as described below. The purpose of this letter is to request
selective review of the Amendment, in accordance with the Commission&#146;s release on selective review,
<I>Revised Procedures For Processing Registration Statements, Post-Effective Amendments and
Preliminary Proxy Materials Filed by Registered Investment Companies</I>, Investment Company Act
Release No.&nbsp;13768 (February&nbsp;15, 1984).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In connection with the Fund&#146;s 2008 universal shelf registration of Common Shares, Preferred
Shares and Debt Securities, the SEC staff reviewed the Fund&#146;s prospectus, forms of prospectus
supplement and statement of additional information. The Fund is requesting selective review of
those portions of the Amendment that are identical to (or substantially identical to) the
registration statement previously filed for the purpose of registering its common shares of
beneficial interest (&#147;<B><I>Common Shares</I></B>&#148;), preferred shares of beneficial interest (&#147;<B><I>Preferred
Shares</I></B>&#148;), debt securities (&#147;<B><I>Debt Securities</I></B>&#148;), or any combination of Common Shares, Preferred
Shares or Debt Securities,
with a proposed maximum aggregate offering price of $75,000,000 (the <B><I>&#147;Shelf Registration
Statement</I></B><I>&#148;</I>), which was declared effective in March&nbsp;2008.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, much of the disclosure relating to the description of securities and plan of
distribution is substantially identical to disclosure in recent universal shelf registration
statements or amendments thereto (the &#147;<B><I>Other Calamos Fund Registration Statements</I></B>&#148;) relating to
common shares of beneficial interest, preferred shares of beneficial interest and debt securities
filed by:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Division of Investment Management<BR>
September&nbsp;1, 2009<BR>
Page 2

</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Calamos Convertible Opportunities and Income Fund (File Nos. 333-146945 and
811-21080) (&#147;<B><I>CHI</I></B>&#148;);</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Calamos Convertible and High Income Fund (File Nos. 333-146947 and 811-21319)
(&#147;<B><I>CHY</I></B>&#148;);</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Calamos Global Dynamic Income Fund (File Nos. 333-153443 and 811-22047) (&#147;<B><I>CHW</I></B>&#148;); and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Calamos Strategic Total Return Fund (File Nos. 333-146943 and 811-21484) (&#147;<B><I>CSQ</I></B>&#148; and
together with CHI, CHY and CHW, the &#147;<B><I>Other Calamos Funds</I></B>&#148;).</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Other Calamos Funds are closed-end investment companies managed by Calamos Advisors LLC,
the investment adviser of the Fund. After the Commission staff provided comments and reviewed the
responses to those comments, the Commission declared the Post-Effective Amendments to each of CHI&#146;s
and CHY&#146;s Registration Statements effective in April&nbsp;2009. The Commission also previously declared
the CSQ Registration Statement effective in March&nbsp;2008, after several rounds of comment letters and
responses. In addition, the Commission staff has reviewed the CHW Registration Statement and
provided comments in January&nbsp;2009, March&nbsp;2009 and August&nbsp;2009. The Fund is requesting selective
review of those portions of the Shelf Registration Statement that are identical to (or
substantially identical to) the Other Calamos Fund Registration Statements, and therefore have been
subject to review by the Commission staff.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As we have discussed, overall, the only substantive differences between the Amendment and the
Shelf Registration Statement and Other Calamos Fund Registration Statements, as appropriate, are:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the Amendment reflects the redemption of all of the Fund&#146;s outstanding Auction Rate
Cumulative Preferred Shares (<B><I>&#147;ARPS&#148;</I></B>), and, as such, does not include the ARPS-specific
disclosure changes requested by the Commission staff during its review of the Other
Calamos Fund Registration Statements; and</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the Amendment describes the terms of the Committed Facility Agreement with BNP
Paribas Prime Brokerage, Inc. (as successor to Bank of America N.A.) that allows the
Fund to borrow up to an initial limit of $59,000,000.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other than as described above, the description of securities and the plan of distribution
disclosed in the Amendment are substantially identical to the same portions of the Shelf
Registration Statement and Other Calamos Fund Registration Statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the paragraphs that follow, I have indicated the specific sections of the Shelf
Registration Statement with respect to which the Fund is requesting selective review.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Division of Investment Management<BR>
September&nbsp;1, 2009<BR>
Page 3

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Please note that I have not indicated in the description below all places where changes were
made to update dates or other information, to reflect the fact that the Fund no longer has ARPS
outstanding, or other changes of a minor or conforming nature.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>Prospectus </B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cover Page</U> &#151;The disclosure on the cover page is substantially identical to the
corresponding disclosure in the same location for the Other Calamos Funds.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Prospectus Summary</U> &#151; I have listed below those subsections of the section captioned
&#147;Prospectus Summary&#148; that are substantially identical to disclosure previously subject to review by
the Commmission staff, and for which the Fund is requesting selective review.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The Fund</I>; <I>Investment Adviser; The Offering; Use of Proceeds; and Dividends and Distributions
on Common Shares</I>. The disclosure in these subsections is substantially identical to the
corresponding disclosure in the Other Calamos Funds&#146; Registration Statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Investment Policies</I>. The disclosure in these subsections is substantially identical to the
corresponding disclosure in the Shelf Registration Statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Use of Leverage by the Fund; Interest Rate Transactions; and Conflicts of Interest</I>. The
disclosure in this subsection is substantially identical to the corresponding disclosure in the
Other Calamos Funds&#146; Registration Statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Fund Risks</I>. The disclosure in this subsection is substantially identical to the disclosure in
the corresponding subsections of the Shelf Registration Statement and the Other Calamos Funds&#146;
Registration Statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Additional Risks to Common Shareholders; and Additional Risks to Senior Security Holders. </I>The
disclosure in this subsection is substantially identical to the corresponding disclosure in the
Other Calamos Funds&#146; Registration Statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Summary of Fund Expenses; Financial Highlights; Market and Net Asset Value Information;
and Use of Proceeds</U> &#151; The disclosure in these sections (aside from specific financial data) is
substantially identical to the corresponding sections of the Other Calamos Funds&#146; Registration
Statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>The Fund; and Investment Objective and Strategies</U> &#151; The disclosure in these sections
is substantially identical to the corresponding sections of the Shelf Registration Statement,
except for
the disclosure under the subsection &#147;Conflicts of Interest&#148;, which is substantially identical
to the corresponding subsection of the Other Calamos Funds&#146; Registration Statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Leverage; and Interest Rate Transactions</U> &#151; The disclosure in these sections is
substantially identical to the corresponding sections of the Other Calamos Funds&#146; Registration
Statements.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Division of Investment Management<BR>
September&nbsp;1, 2009<BR>
Page 4

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Risk Factors</U> &#151; The disclosure in this subsection is substantially identical to the
disclosure in the corresponding subsections of the Shelf Registration Statement and the Other
Calamos Funds&#146; Registration Statements, except for the disclosure under the subsections &#147;Additional
Risks to Common Shareholders&#148; and &#147;Additional Risks to Senior Security Holders&#148;, which is
substantially identical to the corresponding subsection of the Other Calamos Funds&#146; Registration
Statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Management of the Fund</U> &#151; This section is substantially identical to the corresponding
sections of the Shelf Registration Statement and the Other Calamos Funds&#146;Registration Statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Closed-End Fund Structure; Certain Federal Income Tax Matters; Net Asset Value; Dividends
and Distributions on Common Shares; Automatic Dividend Reinvestment Plan; Description of
Securities; Rating Agency Guidelines; Plan of Distribution; Legal Matters; Experts; and Table of
Contents of Statement of Additional Information</U> &#151; The disclosure in these sections is
substantially identical to disclosure in the corresponding sections of the Other Calamos Funds&#146;
Registration Statements. Please note that, as discussed, there is new disclosure in the
Description of Securities section that describes the describes the terms of the Committed Facility
Agreement with BNP Paribas Prime Brokerage, Inc.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain Provisions of the Agreement and Declaration of Trust and By-Laws, Including
Antitakeover Provisions; Custodian, Transfer Agent, Dividend Disbursing Agent and Registrar; and
Available Information</U> &#151; The disclosure in these sections is substantially identical to
disclosure in the corresponding sections of the Shelf Registration Statement and the Other Calamos
Funds&#146; Registration Statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Form of Prospectus Supplements</U> &#151; The forms of prospectus supplements included in the
Amendment are substantially identical to the corresponding sections in the Other Calamos Funds&#146;
Registration Statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>Prospectus Supplement Relating to Common Shares</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cover Page</U> &#151;The disclosure on the cover page is substantially identical to the
corresponding disclosure in the same location for the Other Calamos Funds.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Prospectus Supplement Summary</U> &#151; I have listed below those subsections of the section
captioned &#147;Prospectus Supplement Summary&#148; that are substantially identical to disclosure previously
subject to review by the Commission staff, and for which the Fund is requesting selective review.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The Fund</I>; <I>Investment Adviser; The Offering; and Use of Proceeds</I>. The disclosure in these
subsections is substantially identical to the corresponding disclosure in the Other Calamos Funds&#146;
Registration Statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Capitalization; Financial Highlights; Summary of Fund Expenses; Market and Net Asset Value
Information; Use of Proceeds; Plan of Distribution; Legal Matters; Experts; and Available</u>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Division of Investment Management<BR>
September&nbsp;1, 2009<BR>
Page 5

</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><u>Information</U> &#151; The disclosure in these sections (aside from specific financial data) is
substantially identical to the corresponding sections of the Other Calamos Funds&#146; Registration
Statements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>Statement of Additional Information </B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The disclosure in the Statement of Additional Information included in the Amendment is
substantially identical to the disclosure in the statement of additional information included in
the Other Calamos Funds&#146; Registration Statements, except for the disclosure in the &#147;Investment
Objective and Policies&#148; section, which is substantially identical to the corresponding disclosure
in the Shelf Registration Statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Appendix&nbsp;A of the Statement of Additional Information (&#147;Description of Ratings&#148;) is
substantially identical to Appendix&nbsp;C of the statement of additional information included in the
Shelf Registration Statement, and Appendix&nbsp;B of the statement of additional information included in
the Other Calamos Funds&#146; Registration Statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Please call me or David P. Glatz (312-807-4295) if you have any questions about the enclosed,
or if you require anything further.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Very truly yours,
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Eric S. Purple
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Enclosures
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="95%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">cc:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Stathy Darcy</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Paulita A. Pike</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>c53132c1c5313205.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 c53132c1c5313205.gif
M1TE&.#EAJ0`@`/<``%!04%!144U-3<"^OU)34DY.3D]/3TM+2]S;VU-44U97
M5]+3TTQ,3/GZ^J*AHB@I*51655-55/+S\_W]_<_0T*RMK%I;6O[___[^_9Z>
MGYN;FZ:FI'1U=<+`P:2DI%M;7+V\O<?'QX^0CX"!@=W<W::FII^@GUA86&-D
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MUGIZ>^3FY9B8F(V.CGM[>[.RLX"`@",D),G)R?#P\69F9HV-C=34U+JZN]_B
MX7=W=Y:5E41$1'Q\>____P``````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````"'Y!```````+`````"I`"````C_`&D)'$BPH,&#
M"!,J7,BPH<.'$"-*G$BQHL6+&#-JW,BQH\>/($,FA*&ED,B3*%-B7/!@@,J7
M,&,B9.E2ILV;!#%<\+B@4DV'&!I,H(@#9TZA,G7R]`DQZ-")18T*=/IPS)@!
M=T@@Q/"#SP`8!B>PR7,&%I<7#"%UN..%(4V&&*2XN92D18Q0'G0T>"@C1AV$
M1FI4&%RAAF'"+*P\;?"(!>''%5C<V%NPQP]-9^S&6=-0BI0L`I`<!!7#``01
M*0H.F65`P0P4`@@44:$0C@`M(-RV5$BE1HX$`@`HL'`B``,`+9!H95AE$1Z$
M?@04F&Z`0``#TPL<0$%9A0(``;*+_V>@0`+!"R%H`(A](H(`!7%T+$2`X`"`
M#`9)V(%P!8C!!C088(%_#6RA0`&$[(20`P`P\%-";R&4@A,`&$!'%%A,\L82
MFZQ01G4*\,%0#@J@H&!!'6B@(A)Q!!#!"!FH"$8:3TGP00*.(*+BCAH@8H(,
M!!FA10($S&&$*'MD$D$`LG"6$'WVX4>0&]_EL!R*!1#0`4%;&&!`:@LV^.!,
MNQWT@PT`T,&$"R<.U,`/9X1G4D(L$)!``&!@L!`%!P2`!4(V!L#!4PN-$($3
M)+39@28A`/ED??<-Y(D?%3*24!7'84(0'%X>D1"##NHVID`J/*&`$Y0I5$05
M"C4A0`2.0/^@!5H*\1E`;@=)8`$`@S8T@P)$4`0E`%P(M,,G!=BPP2`)J9`$
M`!:`=001$!"01IL%@3JJ01$2A(-Z"H#%4`\+:1!`"T<DD8`(>_;I`Z"[]LH0
M!PJ@D2I$P^)GA`W`;;E0&#9`\$<;+1`@0+`*.6!`J`MU.Y`.]O&0D2IHLD!+
M%:]>>9"MN!JD*Z^$*K2!``&@L8.>^-87`!(5$``!(ZTXY`,`$40`@1!N1/6I
MF*(:I`<!4#AJT1A10)N:"R@`P`D5"?%)0,<%?2P$M@@-`H8%!420@PEMF-<0
M?0Q`8(/+[#ZT0@(1G.H0@P)L6Y##`A&B0"D9B6"?O[3H$(``7S3_?<#3\!+0
MR08E%&ZX`R$<I`0'!L16@`4W?%T?!!$0H$`G2S0$21Y9!F!=(O>&R;!"<--2
MB@)S*&1$"*RWSL8.(;^10`(HH"S0'Q`PH#%!'`/Z003`"2#\\(L@;!`&E!1M
M0`(`:.#UHP=$\,$*'P#PQ".AGX='`@70H8$2HT100!E*#.1"YMGRW'"9!(T`
M@1P)8?#!\-*%YX3.M&P````E%'1#=2M`B-.@1A!=)>`)IQB!`A?XA4@H!`--
M,(40N-<?A8`M`'J@A1(LH(`#U"`A-RA``#YPI5&T9@8#*<()PI"MO;F-(*4#
M0P+$0*Z#7"`3@!"!#@5Q)T$0I`%B2-M?_P@RAB<DX`1!V-C?"#B00`GA(H!(
M@`)\"+U(T>('"B#`"=)00X($X3NG`)-`!K&"*[C$"R,PV)\(HJV>%:00?2I6
M0_@0'$T)9`*6`(\5:-$`0G#@CQRP0^7L99`!P@MD%FG"[!IA04A)B19K>`(!
M&""Q@E`@;.4SB"=H@0$:``]O`VGC^D;5`!00H`![:$@>(`"%+BHB$%;T`&CH
M]RH&L*&0?WM7KCX@J)`A9`H4`.5`IB"&`"2AD5$B"!7DX+(M"(T64F```71I
M$!@4+`!D.(@H2<<^@I``"A$H@W\2@@,>*,``CZ1%$1+0`LIX81)#B.<01-$'
M&KS/E[:B9M3BY?_+_\2@`%=P@4%>$8`$'+.*Z:3%$L1`@`/TSTVK"``$:$60
M%WQ``1*=03]!)<R#E$X@'3A``AC@"H3T0`0%`$`,IC`04##/8@HQ1'"$V;M=
M!F!J#/&!ES9@$"+8R0_(M")!CO`;!3A`H`)9@!T"8`$3P(`*8;`"B0`P@PI@
MM`Q]R)8!``"(+C#AJZ9@PAO>ULWS[(`3`(``#5:`A1=(01%6B((9`A"`1-!&
M(!(P`P"@,,2$N.`/(Q0C+6KJ,0L0``5D\(!B%^L`'J3J`D403A1NL(,%J.$0
MW/N$8`U"']!DT"!+.`$`#F"&)`I$;\$13@*V&@A+[&0!1)K!O>#`@-77TH\!
M!D@E#,M:D"F8``(I+<!6A=L@*$BB35T(1`$Z>I`P<"^=;<A"`=2`$!6(E@!>
MRJZ7WH-4@<B`%-($@'`-$```.'8A00@"$C*P"83TP0%DX$(J".*%`:P@%(W@
M`"MN\`)"A<`$&;B#[79@`@<8^,")]=1N7SB0)JC!`R*XQ!?F$`L62.*N!#'$
M!B)!-81TH01=($@33."!W;F)!Q[8@(I7K&(/;"%[%#"!"`[Q!5+@89Q2N<A'
B<\SC'KO1QT`.,D(H@0HF"OG(/D:``N2#Y"8[^<DQ"0@`.S\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
